S
ørensen et al. (1) report that in Norway, low concentration of 25-hydroxy-vitamin D [25(OH)D] in mothers during pregnancy was associated with an increased risk of type 1 diabetes in the offspring. We would like to point out that one putative confounding factor in their study might have been the intake of n-3 polyunsaturated fatty acids. Childhood n-3 fatty acid intake and status have been linked with the development of pretype 1 diabetes (2), while reasonably powered prospective studies of exposure during pregnancy are lacking. (5), whereas respective intakes were 3.5 mg and 10.1 mg in Norway (3). Possible other explanations for the different findings between the studies (1,4) include the fact that the samples were collected mainly during the last trimester of pregnancy in Norway, and during the first trimester in Finland. 
